Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Óðîëîãèÿ è àíäðîëîãèÿ > Àäåíîìà èëè äîáðîêà÷åñòâåííàÿ ãèïåðïëàçèÿ ïðåäñòàòåëüíîé æåëåçû

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 20.01.2009, 17:33
Igor1348 Igor1348 âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.01.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Ñêàçàë(à) ñïàñèáî: 1
Igor1348 *
Àäåíîìà ïðåäñòàòåëüíîé æåëåçû

Çäðàâñòâóéòå!
Âîçðàñò 73 ãîäà. Âïåðâûå ïðîÿâèëèñü ïðèçíàêè õðîí. ïðîñòàòèòà è ÄÃÏÆ â 1998ã. Áûëî ïðîâåäåíî îáñëåäîâàíèå â ñòàöèîíàðå. Îáúåì ÏÆ 32 êóá ñì. Íåñêîëüêî ðàç ëå÷èëñÿ ïî ïîâîäó îáîñòðåíèÿ ïðîñòàòèòà.  íàñòîÿùåå âðåìÿ: ÏÑÀ 3,00, ÏÑÀ ñâîáîäíûé 0,645. Îáúåì ÏÆ çà ïîñëåäíèé ãîä óìåíüøèëñÿ ñ 54,3 äî 47,65 êóá. ñì, óçëîâîå îáðàçîâàíèå - ñ 41õ28 äî 39õ27 ìì. Øåñòü ëåò ïîäðÿä ïðèíèìàþ Îìíèê Îêàñ, à òàêæå ïîñëåäîâàòåëüíî - Ïðîñòàìîë, Ãåíòîñ, Öåðíèëòîí, Àôàëà. Ìàêñèìàëüíûé ýôôåêò ïîëó÷åí îò Öåðíèëòîíà.  ïîñëåäíèå ìåñÿöû îòòîê ìî÷è óõóäøèëñÿ. Âîçìîæíî, îðãàíèçì ïðèâûê ê Îìíèêó? Íåëüçÿ ëè çàìåíèòü íà âðåìÿ (èëè ïîñòîÿííî) Îìíèê äðóãèì ïðåïàðàòîì àíàëîãè÷íîãî äåéñòâèÿ?
Çàðàíåå áëàãîäàðåí.
È åùå âîïðîñ: êàê Âû îòíîñèòåñü ê ïðåïàðàòó "Èíäèãàë"?
Ñïàñèáî!
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 21.03.2009, 15:45
Àâàòàð äëÿ Kulikov
Kulikov Kulikov âíå ôîðóìà
ÂÐÀ× ÓÐÎËÎÃ
      
 
Ðåãèñòðàöèÿ: 16.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 3,558
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1,231 ðàç(à) çà 1,203 ñîîáùåíèé
Kulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñ òàêèì îáúåìîì æåëåçû âàì ïîêàçàí â äîïîëíåíèå ê Îìíèêó ïðåïàðàò, êîòîðûé óìåíüøàåò îáúåì æåëåçû - ôèíàñòåðèä èëè äóòàñòåðèä. åñòü ñìûñë îáñóäèòü ýòî ñ ëå÷àùèì âðà÷îì, ÓÇÈ êîíòðîëü ïðîâîäÿò íå ðàíåå ÷åì ÷åðåç 6 ìåñÿöåâ.

Èíäèãàë, ðàâíî êàê è Ïðîñòàìîë, Ãåíòîñ, Öåðíèëòîí, Àôàëà - ýòî ïðåïàðàòà ñ îòñóòñòâèåì íàäåæíûõ äîêàçàòåëüñòâ ýôôåêòèâíîñòè, ïîýòîìó ïðè ëå÷åíèè ïðîñòàòèòà è ÄÃÏÆ íå ðåêîìåíäóþòñÿ.
__________________
Ñ óâàæåíèåì,
Ñåðãåé Íèêîëàåâè÷ Êóëèêîâ
ìîé ïðîô. àêêàóíò â èíñòàãðàì @androlog.kulikov
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 24.03.2009, 12:43
Igor1348 Igor1348 âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.01.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Ñêàçàë(à) ñïàñèáî: 1
Igor1348 *
Ãëóáîêîóâàæàåìûé sergei20!
Áëàãîäàðþ Âàñ çà îòâåò íà ìîé âîïðîñ, îäíàêî íå ìîãó ñîãëàñèòüñÿ ñî ñâàëèâàíèåì â îäíó íåíóæíóþ êó÷ó ãîìåîïàòè÷åñêèõ è ðàñòèòåëüíûõ ïðåïàðàòîâ. ß ñàì ìîãó ïîäòâåðäèòü ïîä ïðèñÿãîé ýôôåêòèâíîñòü äâóõ ïðåïàðàòîâ - Öåðíèëòîíà è Àôàëû, òî æå ìîãóò ñäåëàòü è íåñêîëüêî äðóãèõ ïàöèåíòîâ, îäíàêî ýòè ïðåïàðàòû, ñíèìàÿ âîñïàëåíèå, íå óìåíüøàþò ðàçìåðû ïðîñòàòû, â òî âðåìÿ êàê ñîçäàòåëè Èíäèãàëà îáåùàþò êóïèðîâàòü ðîñò êëåòîê. ×òî êàñàåòñÿ ïðåäëàãàåìîãî Âàìè ôèíàñòåðèäà, òî, Âû õîðîøî çíàåòå, îí âûçûâàåò ïîáî÷íûå ýôôåêòû, òàêèå, êàê ãèíåêîìàñòèÿ è ïð.
Åùå ðàç áëàãîäàðþ Âàñ çà ïîòðà÷åííîå âðåìÿ.
Ñ óâàæåíèåì,
Igor1348
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 24.03.2009, 16:25
Àâàòàð äëÿ Kulikov
Kulikov Kulikov âíå ôîðóìà
ÂÐÀ× ÓÐÎËÎÃ
      
 
Ðåãèñòðàöèÿ: 16.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 3,558
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1,231 ðàç(à) çà 1,203 ñîîáùåíèé
Kulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Åñëè áû îí Âàì ðåàëüíî ïîìîãàë, òî Âû áû íå ïåðåïðîáûâàëè áû ýòó êó÷êó ñ Âàøåé òî÷êè çðåíèÿ ýôôåêòèâíûõ ñðåäñòâ. Ìíå, ñîñåäó îí ïîìîãàåò - ýòî î÷åíü íåäîñòîâåðíûé ïðèçíàê ýôôåêòèâíîñòè è Âàøå îáðàùåíèå ñþäà ïðÿìîå òîìó ñâèäåòåëüñòâî. Äëÿ òîãî ÷òîáû äîêàçàòü ýôôåêò íóæíî ïðîâåñòè äîâîëüíî âíóøèòåëüíûå è äîðîãîñòîÿùèå êëèíè÷åñêèå èññëåäîâàíèÿ íà áîëüøîì êîëè÷åñòâå ïàöèåíòîâ. ó ãîìåîïàòè÷åñêèõ ïðåïàðàòîâ òàêèõ èññëåäîâàíèé íåò âîîáùå.

Ó ôèíàñòåðèäà, äóòàñòåðèäà òàêèå äîêàçàòåëüñòâà åñòü. Îí ñïîñîáåí óìåíüøèòü æåëåçû íà 20-30%, îáëåã÷èòü ñèìïòîìû:

Öèòàòà:
Today, after the completion of many trials, the efficacy of 5-alpha reductase inhibitors is unquestionable
and has been demonstrated over large clinical trials. It can reduce the size of the prostate gland by 20-30%;
it improves symptom scores by approximately 15% and can also cause a moderate improvement in the urinary
flow rate of 1.3-1.6 mL/s (1-4).
A meta-analysis of six randomized clinical trials showed that baseline prostate volume was a key
predictor of various treatment outcomes and that finasteride was more effective in prostates larger than
40 mL (5). Various trials have concluded that finasteride significantly reduced acute urinary retention and the
need for surgical treatment in men with BPH (6-8). In a major placebo controlled trial including 3,040 men,
finasteride-treated patients had significantly less bother, activity interference and worry due to urinary
symptoms.
×òî êàñàåòñÿ ïîáî÷íûõ ýôôåêòîâ, òî óïîìÿíóòàÿ ãèíåêîìàñòèÿ ó ïðèíèìàþùèõ ôèíàñòåðèä âîçíèêàëà ðåæå, ÷åì â 1% ñëó÷àåâ, äðóãèå ñèìïòîìû (ñíèæåíèå ëèáèäî, ñíèæåíèå îáúåìà ýÿêóëÿòà, ýðåêòèëüíàÿ äèñôóíêöèÿ) íå ïðåâûøàëè 8%, ïðîÿâëÿëèñü îáû÷íî ëèøü â 1 ãîä ïðèåìà, èìåëè ñëàáóþ âûðàæåííîñòü è íå ÿâëÿëèñü ïîâîäîì äëÿ îòêàçà îò ïðèåìà ëþäåé èõ óïîòðåáëÿâøèõ, à òàêèõ áûëè òûñÿ÷è (à íå íåñêîëüêî Âàøèõ çíàêîìûõ)

Öèòàòà:
These are mainly related to sexual function. In the PLESS study the side effects reported were decreased libido
(6,4%), impotence (8,1%), decreased ejaculate (3,7%) and in less than 1% of the patients other disorders such
as rash, breast enlargement and breast tenderness (9). All these figures were higher than those observed for
placebo. Such side-effects are considered ‘minimal’ since they did not increase over time and did not cause
many patients to discontinue their treatment. In a recent publication from the PLESS study group it was shown
that the finasteride-related sexual adverse experiences occurred mainly during the first year of therapy (18).
Another conclusion from the PLESS study was that in both older and younger men with symptomatic BPH,
finasteride had the same safety profile and no drug interactions of clinical importance were observed
Ôèíàñòåðèä äîñòîâåðíî èçáåæàòü ðèñêà îñòðîé çàäåðæêè ìî÷è, à òàêæå íåîáõîäèìîñòè îïåðàòèâíîãî ëå÷åíèÿ â áóäóùåì. Òàê ÷òî âûáèðàòü Âàì, íî ñîâåòóþ ïðèíèìàòü ðåøåíèÿ, îñíîâûâàÿñü íà îáúåêòèâíîé èíôîðìàöèè.

Êîììåíòàðèè ê ñîîáùåíèþ:
AlUrS îäîáðèë(à):
Hogan îäîáðèë(à):
__________________
Ñ óâàæåíèåì,
Ñåðãåé Íèêîëàåâè÷ Êóëèêîâ
ìîé ïðîô. àêêàóíò â èíñòàãðàì @androlog.kulikov
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 10.04.2009, 11:14
Igor1348 Igor1348 âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.01.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Ñêàçàë(à) ñïàñèáî: 1
Igor1348 *
Óâàæàåìûé Sergei!
Áëàãîäàðþ Âàñ çà ïîäðîáíîå èçëîæåíèå Âàøåãî ìíåíèÿ, ÷òî çàñòàâèëî ìåíÿ èçìåíèòü ìîþ ïîçèöèþ. Áëàãîäàðþ Âàñ òàêæå çà ïðèâåäåííûå öèòàòû, ÿ äîñòàòî÷íî âëàäåþ àíãëèéñêèì, íî õîòåëîñü áû èìåòü ññûëêó íà èñòî÷íèê. Òåïåðü îñòàåòñÿ òîëüêî óáåäèòü óðîëîãà íàçíà÷èòü ìíå ôèíàñòåðèä, èëè ìîæíî ïîïðîáîâàòü ñàìîìó?

Ñ áëàãîäàðíîñòüþ è óâàæåíèåì
Igor1348.
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 10.04.2009, 11:21
Igor1348 Igor1348 âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 20.01.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 4
Ñêàçàë(à) ñïàñèáî: 1
Igor1348 *
Óâàæàåìûé Ñåðãåè!
Áëàãîäàðþ Âàñ çà ïîäðîáíîå èçëîæåíèå Âàøåãî ìíåíèÿ, ÷òî çàñòàâèëî ìåíÿ èçìåíèòü ìîþ ïîçèöèþ. Áëàãîäàðþ Âàñ òàêæå çà ïðèâåäåííûå öèòàòû, ÿ äîñòàòî÷íî âëàäåþ àíãëèéñêèì, íî õîòåëîñü áû èìåòü ññûëêó íà èñòî÷íèê. Òåïåðü îñòàåòñÿ òîëüêî óáåäèòü óðîëîãà íàçíà÷èòü ìíå ôèíàñòåðèä, èëè ìîæíî ïîïðîáîâàòü ñàìîìó?

Ñ áëàãîäàðíîñòüþ è óâàæåíèåì
Èãîð1348.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 10.04.2009, 14:46
Àâàòàð äëÿ Kulikov
Kulikov Kulikov âíå ôîðóìà
ÂÐÀ× ÓÐÎËÎÃ
      
 
Ðåãèñòðàöèÿ: 16.08.2005
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 3,558
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 1,231 ðàç(à) çà 1,203 ñîîáùåíèé
Kulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåKulikov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Èñòî÷íèê - [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Óðîëîãà íå íóæíî óãîâàðèâàòü. Óõóäøåíèå ñèìïòîìîâ è æåëåçà îáúåìîì áîëåå 40 êóá. ñì ýòî óæå ìåäèöèíñêîå ïîêàçàíèå.
__________________
Ñ óâàæåíèåì,
Ñåðãåé Íèêîëàåâè÷ Êóëèêîâ
ìîé ïðîô. àêêàóíò â èíñòàãðàì @androlog.kulikov
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 23.10.2009, 17:16
Avart Avart âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 14
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
Avart *
Íó, âîò – è ìåíÿ æàðåíûé ïåòóõ êëþíóë.
61 ãîä. Ðåøèë îáñëåäîâàòüñÿ: àíàëèç êðîâè, ìî÷è; ñðåäè ïðî÷åãî PSA - 4,6. Âñïîëîøèëñÿ è ïîø¸ë ê óðîëîãó â ïîëèêëèíèêó. Îí, ïîñëå îáñëåäîâàíèÿ, îïðåäåëèë àäåíîìó ïðîñòàòû, îñòàòî÷íóþ ìî÷ó. Âòîðè÷íûé àíàëèç PSA ïîêàçàë 4,9. Îòïðàâèë â áîëüíèöó íà áèîïñèþ. Òàì êðîìå áèîïñèè ïðîâåëè îáñëåäîâàíèå:
ÓÇÈ Êîíòóðû ïðåäñòàòåëüíîé æåëåçû ÷¸òêèå, íåðîâíûå. Ðàçìåð 52*35*47 ìì, óâåëè÷åí. Îáú¸ì 42 ñì3, óâåëè÷åí. Ïðîñòàòè÷åñêàÿ ÷àñòü óðåòðû âèçóàëèçèðóåòñÿ ñ êàëüêóëåçîì. Êàëüêóëåç îáíàðóæåí. Ñåìåííûå ïóçûðüêè 8 ìì. Ìî÷åâîé ïóçûðü – íà ìîìåíò îñìîòðà 390 ìë. Îñòàòî÷íàÿ ìî÷à 74 ìì.
Ïî÷åìó âñïîëîøèëñÿ? – îòåö óìåð îò îñëîæíåíèÿ ðàêà ïðîñòàòû. À êñòàòè – òóò íàñëåäñòâåííîñòü ìîæåò ñêàçàòüñÿ?
Çà ðåçóëüòàòîì áèîïñèè ïîéäó 27 îêòÿáðÿ.
Õî÷åòñÿ íàäåÿòüñÿ íà «äîáðîêà÷åñòâåííîñòü» àäåíîìû.
Ñîáñòâåííî, ïîäîáðàëñÿ ê ñóòè âîïðîñà.
Åñëè àäåíîìà îêàæåòñÿ òàêîâîé – ñòîèò ëè ñîãëàøàòüñÿ íà îïåðàöèþ? Äà êà÷åñòâî æèçíè ñòðàäàåò, ïî øêàëå IPSS íàáðàë 22 áàëëà. Ýòî, êàê ÿ ïîíÿë, ñâÿçàíî ñ ðàçðàñòàíèåì æåëåçû è òðàíñôîðìàöèè ìî÷åâîãî ïóçûðÿ èç, óñëîâíî ãîâîðÿ, V îáðàçíîé ôîðìû â ñå÷åíèè â W îáðàçíóþ.
Îïåðàöèÿ óëó÷øèò ñèòóàöèþ, íî ïðèâåä¸ò ê ïîòåðå äåòîðîäíîé ôóíêöèè. È õîòü ÿ äåòåé çàâîäèòü íå ñîáèðàþñü (ó ìåíÿ äâîå âçðîñëûõ äåòåé), íî ïîäîçðåâàþ, ÷òî ýòî ìîæåò ñêàçàòüñÿ íà îáùåì ñîñòîÿíèè çäîðîâüÿ. Íó è âîîáùå, êàê áû, íåäîìóæ÷èíà.
×òåíèå ýòîãî òîïèêà ïîìîãëî ìíå óâèäåòü, ÷òî âîçìîæíî êîíñåðâàòèâíîå ëå÷åíèå ñ óìåíüøåíèåì ðàçìåðîâ àäåíîìû. Òàê ìîæåò, ñòîèò ïîïðîáîâàòü?
Íàñêîëüêî çäåñü ìîæåò ïîìî÷ü ëå÷åáíàÿ ôèçêóëüòóðà ïðè ïðîñòàòèòå? Êàê ÿ ïîíèìàþ, å¸ íàçíà÷åíèå â óñèëåíèè êðîâîîáðàùåíèÿ â îáëàñòè ïðîñòàòû.
À åñëè âñ¸ æå òàì îíêî ïðîáëåìû… Ýõ, ìîæåò è ïðèçíàòü ýâòàíàçèþ?
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 23.10.2009, 17:32
Hogan Hogan âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 25.09.2005
Ãîðîä: ....
Ñîîáùåíèé: 1,637
Ïîáëàãîäàðèëè 307 ðàç(à) çà 293 ñîîáùåíèé
Hogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàñëåäñòâåííîñòü íåñîìíåííî. Ïðè íàëè÷èè ÐÏ ó îòöà èëè áðàòà îòöà, ñêðèíèíã (îïðåäåëåíèå ÏÑÀ+ïàëüöåâîå èññëåäîâàíèå) ñ 40ë âîçðàñòà íóæíî íà÷èíàòü.
22 áàëà ïî IPSS ýòî êîíå÷íî æå ñóùåñòâåííî, íî îáúåêòèâíûå ìåòîäû îáñëåäîâàíèÿ âàæíåå. Ýòî îñò. ìî÷à è óðîôëîóìåòðèÿ.  ñèìïòîìîêîìïëåêñå íèæíèõ ìî÷åâûõ ïóòåé åñòü îáñòóêòèâíûå è èððèòàòèâíûå ñîñòàâëÿþùèå. Äåòàëüíûé ðàçáîð äî îïåðàöèè, ïîìîæåò îïðåäåëèòüñÿ ñ íåîáõîäèìîñòüþ îïåðàöèè è îæèäàíèé îò íåå.
Íî ïåðâûì äåëîì áèîïñèÿ. Äàâàéòå äîæèäàòüñÿ ðåçóëüòàòîâ. Êñòàòè, ãäå äåëàëè áèîïñèþ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 23.10.2009, 17:40
Avart Avart âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 14
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
Avart *
Hogan
Äà, ÿ ïîíèìàþ. Áèîïñèþ äåëàë â 12 ÃÊÁ, Ìîñêâà
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 23.10.2009, 17:50
Hogan Hogan âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 25.09.2005
Ãîðîä: ....
Ñîîáùåíèé: 1,637
Ïîáëàãîäàðèëè 307 ðàç(à) çà 293 ñîîáùåíèé
Hogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàïèøèòå çäåñü äàííûå ðåçóëüòàòà áèîïñèè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 23.10.2009, 18:05
Avart Avart âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 14
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
Avart *
Hogan
Äà. Êàê òîëüêî áóäåò ãîòîâî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 28.10.2009, 11:09
Avart Avart âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 14
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
Avart *
Ðåçóëüòàòû áèîïñèéíîãî èññëåäîâàíèÿ

Ìàêðîñêîïè÷åñêîå îïèñàíèå:

1. Ñòîëáèê áåëåñîâàòî-ñåðîé òêàíè äëèíîé 1,1 ñì.
2. Ñòîëáèê áåëåñîâàòî-ñåðîé òêàíè äëèíîé 0,7 ñì.
3. Ñòîëáèê áåëåñîâàòî-ñåðîé òêàíè äëèíîé 0,8 ñì.
4. Ñòîëáèê òêàíè ñâåòëî-êîðè÷íåâîãî öâåòà äëèíîé 0,7 ñì.
5. Ñòîëáèê áåëåñîâàòî-ñåðîé òêàíè äëèíîé 0,4 ñì.
6. Ñòîëáèê ñâåòëî-êîðè÷íåâîé òêàíè äëèíîé 0,5 ñì.
7. Ñòîëáèê áåëåñîâàòî-ñåðîé òêàíè äëèíîé 0,7 ñì.
8. Ñòîëáèê ñâåòëî-ñåðîé òêàíè äëèíîé 1,0 ñì.
9. Ñâåòëî-êîðè÷íåâûé ôðàãìåíò äëèíîé 1,0 ñì.
10. Ñâåòëî-ñåðûé íèòåâèäíûé ôðàãìåíò äëèíîé 0,8 ñì.
11. Ñòîëáèê ñâåòëî-ñåðîé òêàíè äëèíîé 0,8 ñì.
12. Åäâà çàìåòíûå ñâåòëî-ñåðûå êðîøêîâèäíûå ôðàãìåíòû

Ó÷èòûâàÿ êëèíè÷åñêèé äèàãíîç, õàðàêòåð áèîïñèéíîãî ìàòåðèàëà, ïðèìåí¸í äîïîëíèòåëüíûé ìåòîä îêðàøèâàíèÿ ïî Âàí-Ãèçîíó äëÿ èçó÷åíèÿ äåñìîïëàñòè÷åñêîé ðåàêöèè ñòðîìû è óðîâíÿ èíâàçèè.

Ìèêðîñêîïè÷åñêîå îïèñàíèå:

Ôðàãìåíòû òêàíè ïðåäñòàòåëüíîé æåëåçû ñ êðóïíûìè ôåñòîí÷àòûìè æåëåçàìè èç âûñîêîãî, ñâåòëîãî, ìåñòàìè ïðîëèôåðèðóþùåãî ýïèòåëèÿ, åäèíè÷íûå æåëåçû êèñòîçíî ðàñøèðåíû, ñîäåðæàò êîíêðåìåíòû, î÷àãîâàÿ àòðîôèÿ æåëåç; î÷àãîâàÿ ñêóäíàÿ ëèìôî-ãèñòèîöèòàðíàÿ èíôèëüòðàöèÿ ñòðîìû.
Æåëåçèñòàÿ ãèïåðïëàçèÿ ïðåäñòàòåëüíîé æåëåçû. Ïðèçíàêîâ îïóõîëåâîãî ðîñòà íå âûÿâëåíî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 28.10.2009, 11:20
Hogan Hogan âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 25.09.2005
Ãîðîä: ....
Ñîîáùåíèé: 1,637
Ïîáëàãîäàðèëè 307 ðàç(à) çà 293 ñîîáùåíèé
Hogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåHogan ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ðåçóëüòàò áèîïñèè ÏÎÊÀ õîðîøèé! Ïîêà, ïîòîìó ÷òî àíàìíåç îòÿãîùåííûé, òðåáóåò ïîñëåäóþùèõ êîíòðîëåé ÏÑÀ. Íàëè÷èå âûðàæåííûõ ñèìïòîìîâ è îñò. ìî÷è òðåáóåò áîëåå àêòèâíîãî íàáëþäåíèÿ è, ïðè îòñóòñòâèè (+) äèíàìèêè îò êîíñåðâàòèâíîãî ëå÷åíèÿ, ïîäóìàòü îá îïåðàòèâíîì ëå÷åíèè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 28.10.2009, 11:37
Avart Avart âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 14
Ñêàçàë(à) ñïàñèáî: 5
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
Avart *
Îõ! Íå ìîãó íå ñêàçàòü, ÷òî â îæèäàíèè ðåçóëüòàòà æèë â ñîñòîÿíèè ïåðìàíåíòíîãî ñòðåññà.
Âðà÷ â ïîëèêëèíèêå - íàçíà÷èë Îìíèê Îêàñ â òå÷åíèå ïîëóãîäà è ñêàçàë ïîäîéòè ÷åðåç äâà ìåñÿöà. Íà ìîþ ïðîñüáó ðàññìîòðåòü âîçìîæíîñòü íàçíà÷åíèÿ ôèíàñòåðèäà èëè äóòàñòåðèäà îòâåòèë, ÷òî íåëüçÿ - íà ôîíå ïîâûøåííîãî ÏÑÀ. Íî îìíèê - íå óìåíüøàåò ðàçìåðû! Âîçìîæíî ëè ñíèçèòü ÏÑÀ, ñ òåì ÷îáû íà÷àòü èõ ïðè¸ì? Ñïîñîáñòâóåò ëè ýòîìó îìíèê? Íàñêîëüêî ïîëåçíà ëå÷åáíàÿ ôèçêóëüòóðà îò ïðîñòàòèòà?
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 08:11.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.